41
|
Applanatumol V |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
42
|
Applanatumol W |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
43
|
Applanatumol X |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
44
|
Applanatumol Y |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
45
|
Applanatumol Z |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
46
|
Applanatumol Z2 |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
47
|
Applanatumol K |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
48
|
Applanatumol L |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
49
|
Applanatumol M |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
50
|
Applanatumol N |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
51
|
Applanatumol O |
Inhibitory activities against COX-1 and COX-2 |
G. applanatum
|
[32] |
52
|
Chizhiol A |
Inhibitory activities against COX-1 and COX-2 |
G. lucidum
|
[39] |
53
|
Ganotheaecoloid L |
Inhibitory activities against COX-1 and COX-2 |
G. theaecolum
|
[40] |
54
|
(+)-Ganotheaecoloid M |
Inhibitory activities against COX-1 and COX-2 |
G. theaecolum
|
[40] |
55
|
(−)-Ganotheaecoloid N |
Inhibitory activities against COX-1 and COX-2 |
G. theaecoloum
|
[40] |
56
|
Petchiene A |
Inhibitory activities against COX-1 and COX-2 |
G. petchii
|
[41] |
57
|
Lingzhine C |
Promote proliferation of neural stem cells (NSCs) |
G. lucidum
|
[38] |
58
|
(±)-Lingzhine B |
Inhibit NSC proliferation |
G. lucidum
|
[38] |
59
|
(−)-Ganotheaecoloid A |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
60
|
(−)-Ganotheaecoloid B |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
61
|
Ganotheaecoloid C |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
62
|
Ganotheaecoloid D |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
63
|
Ganotheaecoloid E |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
64
|
(−)-Ganotheaecoloid F |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
65
|
Ganotheaecoloid G |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
66
|
Ganotheaecoloid H |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
67
|
Ganotheaecoloid I |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
68
|
(+)-Ganotheaecoloid J |
COX-2 inhibitory activity (IC50: 9.96 μM) |
G. theaecolum
|
[40] |
69
|
Ganotheaecoloid K |
Inhibitory activities against COX-2 |
G. theaecolum
|
[40] |
70
|
(+)-Cochlearin A |
Antioxidant activity |
G. cochlear
|
[30] |
71
|
Spiroapplanatumine A |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
72
|
Spiroapplanatumine C |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
73
|
Spiroapplanatumine E |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
74
|
Spiroapplanatumine G |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
75
|
Spiroapplanatumine I |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
76
|
Spiroapplanatumine B |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
77
|
Spiroapplanatumine D |
Inhibitory activities against JAK3 kinase (IC50: 7.0 ± 3.2 μM) |
G. applanatum
|
[42] |
78
|
Spiroapplanatumine F |
Inhibitory activities against JAK3 kinase (IC50: 34.8 ± 21.1 μM) |
G. applanatum
|
[42] |
79
|
Spiroapplanatumine H |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
80
|
Spiroapplanatumine J |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
81
|
Spiroapplanatumine K |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
82
|
Spiroapplanatumine L |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
83
|
Spiroapplanatumine M |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
84
|
(+)-Spiroapplanatumine N |
Inhibitory activity against JAK3 kinase |
G. applanatum
|
[42] |
85
|
Spiroapplanatumine O |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
86
|
(−)-Spiroapplanatumine N |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
87
|
Spiroapplanatumine P |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
88
|
Spiroapplanatumine Q |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[42] |
89
|
(+)- Spirolingzhine A |
Protective effects for NSC |
G. lucidum
|
[38] |
90
|
(+)-Spirolingzhine B |
Protective effects for NSC |
G. lucidum
|
[38] |
91
|
(+)-Spirolingzhine C |
Protective effects for NSC |
G. lucidum
|
[38] |
92
|
Spirolingzhine D |
Protective effects for NSC |
G. lucidum
|
[38] |
93
|
(±)-Ganoderin A |
Antioxidant activity |
G. cochlear
|
[15] |
94
|
Applanatumol H |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
95
|
Applanatumol I |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
96
|
Applanatumol J |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
97
|
Applanatumol D |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
98
|
Applanatumol E |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
99
|
Applanatumol J |
Inhibitory activities against COX-1, COX-2 |
G. applanatum
|
[32] |
100
|
Applanatumol F |
Inhibitory activities against J COX-1, COX-2 |
G. applanatum
|
[32] |
101
|
Lingzhilactone A |
Renoprotective effect |
G. lucidum
|
[43] |
102
|
Lingzhilactone B |
Renoprotective effect |
G. lucidum
|
[43] |
103
|
Lingzhilactone C |
Renoprotective effect |
G. lucidum
|
[43] |
104
|
Applanatumol Z3 |
Inhibitory activities against JAK3 kinase |
G. applanatum
|
[32] |
105
|
Applanatumol Z4 |
Inhibitory activities against JAK3 and DDR1 kinases |
G. applanatum
|
[32] |
106
|
Applanatumol C |
Inhibitory activities against JAK3 and DDR1 kinases |
G. applanatum
|
[32] |
107
|
(−)-Lingzhiol |
Renoprotective effect |
G. lucidum
|
[44] |
108
|
(±)-Ganocochlearin A |
Antioxidant activity |
G. cochlear
|
[15] |
109
|
(±)-Ganocochlearin B |
Antioxidant activity |
G. cochlear
|
[15] |
110
|
(±)-Ganocochlearin C |
Antioxidant activity |
G. cochlear
|
[15] |
111
|
(±)-Ganocochlearin D |
Antioxidant activity |
G. cochlear
|
[15] |
112
|
Lingzhine D |
Anti-BuChE activity |
G. lucidum
|
[38] |
113
|
(±)-Ganocin A |
Anti-BuChE activity |
G. cochlear
|
[45] |
114
|
(±)-Ganocin B |
Anti-BuChE activity |
G. cochlear
|
[45] |
115
|
(±)-Ganocin C |
Anti-BuChE activity |
G. cochlear
|
[45] |
116
|
(±)-Ganocin D |
Anti-BuChE activity |
G. cochlear
|
[45] |
117
|
Cochlearol A |
Renoprotective effect |
G. cochlear
|
[46] |
118
|
Cochlearol B |
Renoprotective effect |
G. cochlear
|
[46] |
119
|
Applanatumol A |
Anti-renal fibrosis |
G. applanatum
|
[18] |
120
|
(±)-Applanatumol B |
Anti-renal fibrosis |
G. applanatum
|
[18] |